Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ALT – Altimmune Inc

Name : Altimmune, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $0.0000
EPSttm :
finviz dynamic chart for ALT
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ALT #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ALT &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

21.04

Margin Of Safety %

Put/Call OI Ratio

0.24

EPS Next Q Diff

-0.95

EPS Last/This Y

0.35

EPS This/Next Y

-0.33

Price

4.2

Target Price

17.88

Analyst Recom

1.67

Performance Q

15.75

Relative Volume

0.82

Beta

-0.01

Ticker: ALT




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-10-20ALT40.250.08195591
2025-10-21ALT4.030.240.22201685
2025-10-22ALT3.890.240.05204199
2025-10-23ALT3.950.240.22205333
2025-10-24ALT3.940.240.28207996
2025-10-27ALT4.140.240.09205422
2025-10-28ALT4.050.240.24209261
2025-10-29ALT40.240.14211369
2025-10-30ALT4.060.240.13212184
2025-10-31ALT4.050.240.71214837
2025-11-03ALT3.950.250.23210081
2025-11-04ALT3.760.250.25212559
2025-11-05ALT3.730.250.23216117
2025-11-06ALT3.930.250.25217502
2025-11-07ALT4.10.230.21236772
2025-11-10ALT4.250.220.42231971
2025-11-11ALT4.280.221.51235184
2025-11-12ALT4.230.231.46238628
2025-11-13ALT4.050.230.23240244
2025-11-14ALT4.160.230.20240729
2025-11-17ALT4.20.240.18232070
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-10-20ALT4.0017.0-97.6-1.13
2025-10-21ALT4.0317.0-85.1-1.13
2025-10-22ALT3.9017.0-71.0-1.13
2025-10-23ALT3.9517.0-86.7-1.13
2025-10-24ALT3.9417.0-81.0-1.13
2025-10-27ALT4.1417.0-97.4-1.13
2025-10-28ALT4.0617.0-76.2-1.13
2025-10-29ALT3.9917.0-77.3-1.13
2025-10-30ALT4.0717.0-88.3-1.13
2025-10-31ALT4.0517.0-81.6-1.13
2025-11-03ALT3.9617.0-75.2-1.13
2025-11-04ALT3.7617.0-65.3-1.13
2025-11-05ALT3.7317.0-79.6-1.13
2025-11-06ALT3.9317.0-98.7-1.13
2025-11-07ALT4.1117.0-97.0-1.13
2025-11-10ALT4.2617.0-93.5-1.13
2025-11-11ALT4.2817.0-88.4-0.99
2025-11-12ALT4.2317.0-83.4-0.99
2025-11-13ALT4.0617.0-74.9-0.99
2025-11-14ALT4.1724.7-95.5-0.99
2025-11-17ALT4.2024.7-89.5-0.99
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-10-20ALT0.00-0.8929.97
2025-10-21ALT0.00-0.8929.97
2025-10-22ALT0.00-0.8929.97
2025-10-23ALT0.00-0.8929.97
2025-10-24ALT0.00-0.8929.97
2025-10-27ALT0.00-1.2924.61
2025-10-28ALT0.00-1.290
2025-10-29ALT0.00-1.2924.61
2025-10-30ALT0.00-1.2924.61
2025-10-31ALT0.00-1.2924.61
2025-11-03ALT0.00-1.3224.61
2025-11-04ALT0.00-1.3224.61
2025-11-05ALT0.00-1.3224.61
2025-11-06ALT0.00-1.3224.61
2025-11-07ALT0.00-1.3224.56
2025-11-10ALT0.00-3.0824.56
2025-11-11ALT0.00-3.080
2025-11-12ALT0.00-3.0821.04
2025-11-13ALT0.00-3.0821.04
2025-11-14ALT0.00-3.0821.04
2025-11-17ALT0.00-1.0721.04
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ALT 589 360 ]

Last Quarter Act. EPS

0.67

Avg. EPS Est. Current Quarter

-0.25

Avg. EPS Est. Next Quarter

-0.28

Insider Transactions

Institutional Transactions

-1.07

Beta

-0.01

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

24

Growth Score

23

Sentiment Score

81

Actual DrawDown %

82.9

Max Drawdown 5-Year %

-91.2

Target Price

17.88

P/E

Forward P/E

PEG

P/S

21859.84

P/B

2.16

P/Free Cash Flow

EPS

-1.07

Average EPS Est. Cur. Y​

-0.99

EPS Next Y. (Est.)

-1.32

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-419575

Relative Volume

0.82

Return on Equity vs Sector %

-72.2

Return on Equity vs Industry %

-57.2

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.14

EBIT Estimation

-89.5
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ALT 589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ALT 589 450 ]
Altimmune, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 59
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
stock quote shares ALT – Altimmune Inc Stock Price stock today
news today ALT – Altimmune Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune Inc yahoo finance google finance
stock history ALT – Altimmune Inc invest stock market
stock prices ALT premarket after hours
ticker ALT fair value insiders trading

ALT – Altimmune, Inc.

Altimmune, Inc.
ALT
$4.19
Name : Altimmune, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $437,194,592.00
EPSttm : -1.07
finviz dynamic chart for ALT
Altimmune, Inc.
$4.19
0.48%
$0.02

Float Short %

21.04

Margin Of Safety %

Put/Call OI Ratio

0.24

EPS Next Q Diff

-0.95

EPS Last/This Y

0.35

EPS This/Next Y

-0.33

Price

4.2

Target Price

17.88

Analyst Recom

1.67

Performance Q

15.75

Relative Volume

0.82

Beta

-0.01

Ticker: ALT




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-10-20ALT40.250.08195591
2025-10-21ALT4.030.240.22201685
2025-10-22ALT3.890.240.05204199
2025-10-23ALT3.950.240.22205333
2025-10-24ALT3.940.240.28207996
2025-10-27ALT4.140.240.09205422
2025-10-28ALT4.050.240.24209261
2025-10-29ALT40.240.14211369
2025-10-30ALT4.060.240.13212184
2025-10-31ALT4.050.240.71214837
2025-11-03ALT3.950.250.23210081
2025-11-04ALT3.760.250.25212559
2025-11-05ALT3.730.250.23216117
2025-11-06ALT3.930.250.25217502
2025-11-07ALT4.10.230.21236772
2025-11-10ALT4.250.220.42231971
2025-11-11ALT4.280.221.51235184
2025-11-12ALT4.230.231.46238628
2025-11-13ALT4.050.230.23240244
2025-11-14ALT4.160.230.20240729
2025-11-17ALT4.20.240.18232070
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-10-20ALT4.0017.0-97.6-1.13
2025-10-21ALT4.0317.0-85.1-1.13
2025-10-22ALT3.9017.0-71.0-1.13
2025-10-23ALT3.9517.0-86.7-1.13
2025-10-24ALT3.9417.0-81.0-1.13
2025-10-27ALT4.1417.0-97.4-1.13
2025-10-28ALT4.0617.0-76.2-1.13
2025-10-29ALT3.9917.0-77.3-1.13
2025-10-30ALT4.0717.0-88.3-1.13
2025-10-31ALT4.0517.0-81.6-1.13
2025-11-03ALT3.9617.0-75.2-1.13
2025-11-04ALT3.7617.0-65.3-1.13
2025-11-05ALT3.7317.0-79.6-1.13
2025-11-06ALT3.9317.0-98.7-1.13
2025-11-07ALT4.1117.0-97.0-1.13
2025-11-10ALT4.2617.0-93.5-1.13
2025-11-11ALT4.2817.0-88.4-0.99
2025-11-12ALT4.2317.0-83.4-0.99
2025-11-13ALT4.0617.0-74.9-0.99
2025-11-14ALT4.1724.7-95.5-0.99
2025-11-17ALT4.2024.7-89.5-0.99
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-10-20ALT0.00-0.8929.97
2025-10-21ALT0.00-0.8929.97
2025-10-22ALT0.00-0.8929.97
2025-10-23ALT0.00-0.8929.97
2025-10-24ALT0.00-0.8929.97
2025-10-27ALT0.00-1.2924.61
2025-10-28ALT0.00-1.290
2025-10-29ALT0.00-1.2924.61
2025-10-30ALT0.00-1.2924.61
2025-10-31ALT0.00-1.2924.61
2025-11-03ALT0.00-1.3224.61
2025-11-04ALT0.00-1.3224.61
2025-11-05ALT0.00-1.3224.61
2025-11-06ALT0.00-1.3224.61
2025-11-07ALT0.00-1.3224.56
2025-11-10ALT0.00-3.0824.56
2025-11-11ALT0.00-3.080
2025-11-12ALT0.00-3.0821.04
2025-11-13ALT0.00-3.0821.04
2025-11-14ALT0.00-3.0821.04
2025-11-17ALT0.00-1.0721.04
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.67

Avg. EPS Est. Current Quarter

-0.25

Avg. EPS Est. Next Quarter

-0.28

Insider Transactions

Institutional Transactions

-1.07

Beta

-0.01

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

24

Growth Score

23

Sentiment Score

81

Actual DrawDown %

82.9

Max Drawdown 5-Year %

-91.2

Target Price

17.88

P/E

Forward P/E

PEG

P/S

21859.84

P/B

2.16

P/Free Cash Flow

EPS

-1.07

Average EPS Est. Cur. Y​

-0.99

EPS Next Y. (Est.)

-1.32

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-419575

Relative Volume

0.82

Return on Equity vs Sector %

-72.2

Return on Equity vs Industry %

-57.2

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.14

EBIT Estimation

-89.5
Altimmune, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 59
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
stock quote shares ALT – Altimmune, Inc. Stock Price stock today
news today ALT – Altimmune, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune, Inc. yahoo finance google finance
stock history ALT – Altimmune, Inc. invest stock market
stock prices ALT premarket after hours
ticker ALT fair value insiders trading